Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Forconi, S. | Guerrini, M. | Cappelli, R. | Furesi, L. | Battistelli, S. | Sani, P. | Marotta, G. | Trabalzini, L.
Affiliations: Istituto di Semeiotica Medica e Geriatria, Università di Siena, Italy
Abstract: This study concerns the effect of intravenous thrombolysis in patients suffering from Peripheral Obliterative Arterial Disease (POAD) at the stage of “Accelerated Limb Ischemia” (ALI). In a previous study on 17 patients, where Streptokinase was employed, there was complete or partial reopening of obstructed vessels in 5 cases and an improvement of clinical conditions in 10 cases. Unfortunately, 6 (35%) patients experienced significant side effects. Subsequently, in 9 POAD patients, we employed rt-PA at the dosage of 100 mg infused i.v. over a period of 4–6 hours. This treatment showed a clinical and instrumental improvement in a high percentage of patients without any important side effects. The effect of the treatment was examined by means of Doppler ultrasound, strain gauge plethysmography and Transcutaneous oxygen tension (TcPO2). Haemorheological and fibrinolytic parameters were also assessed and no important changes were observed either in blood or plasma viscosity in spite of the reduction of fibrinogen concentration (especially in the Streptokinase group) and the improvement of leg perfusion. Explanation of this aspect was sought through an “in vitro” study: here rt-PA was added to blood samples so as to obtain a more definite fibrinolysis. Before and after the addition of rt-PA, blood and plasma viscosity, fibrinogen, FDP and FDP-E were examined. The results illustrated that the reduction of plasma and blood viscosity was not as significant as the disappearance of fibrinogen might have led us to expect and showed a marked increase of fibrinogenolytic products (FDP and FDP-E). These findings reinforce the working hypothesis stating that fibrino(geno)lytic products can affect plasma and blood viscosity as much as the intact fibrinogen molecule does. So it was concluded that the beneficial results obtained with fibrinolytic agents, in patient with POAD at the ALI stage, are due to the reopening of vessels and not to the rheological effect.
Keywords: thrombolysis, fibrin(ogen) degradation products, blood viscosity
DOI: 10.3233/CH-1993-13103
Journal: Clinical Hemorheology and Microcirculation, vol. 13, no. 1, pp. 13-22, 1993
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]